The Misuse of Drugs and Misuse of Drugs (Designation) (England and Wales and Scotland) (Amendment and Revocation) Regulations 2024

• Citation: S.I. 2024/248
• Sections: 4

Section 1 Citation, commencement and extent

(1) These Regulations may be cited as the Misuse of Drugs and Misuse of Drugs (Designation) (England and Wales and Scotland) (Amendment and Revocation) Regulations 2024.

(2) These Regulations come into force as follows—

(a) this regulation and regulation 4 come into force on 19th March 2024; and

(b) the remaining regulations come into force on 20th March 2024.

(3) These Regulations extend to England and Wales and Scotland.

Section 2 Amendment of the Misuse of Drugs Regulations 2001

(1) The following amendments are made to the Misuse of Drugs Regulations 2001 .

(2) In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—

(a) after “Bromazolam (8-bromo-1-methyl-6-phenyl-4 H -[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine” ;

(b) after “Bufotenine” insert “Butonitazene” ;

(c) after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4 H -[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene” ;

(d) after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone” ;

(e) after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol” insert—

Diphenidine

Ephenidine

Ethyleneoxynitazene

(f) after “Etizolam” insert—

Etodesnitazene (etazene)

Etonitazene

(g) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4 H -[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene” ;

(h) after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene” ;

(i) after “Methcathinone” insert “Methoxyphenidine” ;

(j) after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6 H -thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—

Metodesnitazene (metazene)

Metonitazene

(k) after “Propylphenidate” insert “Protonitazene” ;

(l) after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—

N -Desethyl etonitazene

N -Desethylisotonitazene

N -Desethyl protonitazene

(m) after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—

N -Piperidinyl-etonitazene (etonitazepipne)

N -Pyrrolidino-etonitazene (etoniazepyne)

N -Pyrrolidino protonitazene

(3) In paragraph 1 of Schedule 2 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 16A, 18, 19, 20, 21, 23, 26 and 27) omit “Clonitazene” and “Etonitazene”.

(4) In paragraph 1 of Part 1 of Schedule 4 (which specifies controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) after “Pyrovalerone” insert “Remimazolam” .

Section 3 Amendment of the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015

(1) The following amendments are made to Schedule 1 to the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 (which specifies controlled drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies).

(2) In paragraph 1(a)—

(a) after “Bromazolam (8-bromo-1-methyl-6-phenyl-4 H -[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine” ;

(b) after “1,4-Butanediol” insert “Butonitazene” ;

(c) after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4 H -[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene” ;

(d) after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone” ;

(e) after “Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2 H -1,4-benzodiazepin-2-one)” insert—

Diphenidine

Ephenidine

Ethyleneoxynitazene

(f) after “Etizolam” insert—

Etodesnitazene (etazene)

Etonitazene

(g) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4 H -[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene” ;

(h) after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene” ;

(i) after “Methcathinone” insert “Methoxyphenidine” ;

(j) after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6 H -thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—

Metodesnitazene (metazene)

Metonitazene

(k) after “Propylphenidate” insert “Protonitazene” ;

(l) after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—

N -Desethyl etonitazene

N -Desethylisotonitazene

N -Desethyl protonitazene

(m) after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—

N -Piperidinyl-etonitazene (etonitazepipne)

N -Pyrrolidino-etonitazene (etoniazepyne)

N -Pyrrolidino protonitazene

Section 4 Revocation of the Misuse of Drugs and Misuse of Drugs (Designation) (England and Wales and Scotland) (Amendment) Regulations 2024

The Misuse of Drugs and Misuse of Drugs (Designation) (England and Wales and Scotland) (Amendment) Regulations 2024 are revoked.